News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Theragenics Corporation (TGX) Announces Stockholder Approval of Merger Agreement With Juniper



10/17/2013 10:58:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX) (the “Company”), a medical device company serving the surgical products and prostate cancer treatment markets, announced today that the stockholders of the Company voted to approve the previously announced merger agreement providing for a newly formed affiliate of Juniper Investment Company, LLC to acquire all of the outstanding common stock of the Company for $2.20 per share in cash.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES